Vector-borne diseases (VBDs) are a significant public health concern in India, with rising prevalence rates. These diseases, transmitted by vectors like mosquitoes, ticks, and fleas, pose a substantial challenge to healthcare professionals due to their complex epidemiology and management.
Recent years have seen an upsurge in VBDs in India, including dengue, malaria, and chikungunya. Rapid urbanization, climate change, and increased international travel contribute to this rise. Additionally, the resistance of vectors to insecticides and parasites to drugs further complicates the situation.
Healthcare professionals face multiple challenges in managing VBDs. These include early detection, correct diagnosis, and effective treatment. The lack of specific diagnostic tools and the high cost of treatment often lead to delayed or inadequate care. Furthermore, the co-circulation of multiple VBDs often results in misdiagnosis.
Effective management of VBDs requires a multi-pronged approach. This includes strengthening surveillance systems for early detection and prompt response, improving diagnostic facilities, and promoting research on drug resistance. Public health education is also crucial to prevent vector breeding and encourage early health-seeking behavior.
Healthcare professionals play a pivotal role in managing VBDs. Their responsibilities extend beyond clinical care to include educating patients and their communities, advocating for policy changes, and participating in research. They are the frontline in the fight against these diseases and their impact on public health.
The rising prevalence of VBDs in India is a pressing health issue that requires concerted efforts from all stakeholders. Healthcare professionals, with their unique position and skills, can significantly contribute to managing these diseases, ultimately improving public health outcomes.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation